DUBLIN, Ireland, November 10, 2014 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/846jsz/incretion_drugs) has announced the addition of the "Incretion Drugs Markets in China" report to their offering.
China's demand for Incretion Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2003, 2008 and 2013) and long-term forecasts through 2018 and 2023 are presented.
The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments' industry bureaus, industry publications, and our in-house databases. Interviews are conducted with Chinese industry experts, university professors, and producers in China. Economic models and quantitative methods are applied in this report to project market demand and industry trends. Metric system is used and values are presented in either Yuan (RMB, current price) and/or US dollars.
Our market research reports provide hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous fast-growing markets for imports and business opportunities for companies around the world.
Key Topics Covered:
II. BUSINESS ENVIRONMENT
III. INCRETION DRUGS INDUSTRY ASSESSMENTS
IV. INCRETION DRUGS PRODUCTION AND DEMAND
V. INCRETION DRUGS MARKET OUTLOOK
VI. MARKETING STRATEGIES
VII. INCRETION DRUGS PRODUCER DIRECTORY
- Zhongmei Shanghai Squibb Pharmaceutical Co., Ltd
- Beijing Liling Pharmaceutical Co., Ltd
For more information visit http://www.researchandmarkets.com/research/846jsz/incretion_drugs
Media Contact: Laura Wood , +353-1-481-1716, [email protected]
SOURCE Research and Markets